The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: The Austrian pharmaceutical market, despite its small size in comparison with its EU15
partners, has one of the highest per capita expenditures globally due to its relatively small population, high
burden of non-communicable diseases and ageing population. We believe pharmaceutical spending will
post modest growth over the medium term as the government links growth in public healthcare expenditure
with nominal GDP growth. Overall, we view the Austrian pharmaceutical and healthcare market as
relatively stable and insulated from sudden downgrades.
Headline Expenditure Projections
? Pharmaceuticals: EUR6.29bn (USD6.97bn) in 2015 to EUR6.48bn (USD6.94bn) in 2016; 3.15% in local
currency terms and -0.5% in US dollar terms. Forecasts slightly decreased from the previous quarter.
? Healthcare: EUR37.4bn (USD41.4bn) in 2015 to EUR38.9bn (USD41.6bn) in 2016; +4.1% in local
currency terms and 0.4% in US dollar terms. Forecasts unchanged from the previous quarter.